Ethics Committee Registration Requirements in India

Published on 21/12/2025

Step-by-Step Guide to Ethics Committee Registration for Indian Clinical Trials

Introduction

Ethics Committees (ECs) play a critical role in ensuring that clinical trials in India are conducted ethically, safeguarding the rights, safety, and well-being of trial participants. With India’s growing presence in global clinical research, the regulatory framework has been strengthened to enforce stricter oversight of these committees. The registration of ECs with the Central Drugs Standard Control Organization (CDSCO) is mandatory before any clinical trial involving human subjects can commence. This requirement ensures that all ECs reviewing and approving trials meet the standards set out in the New Drugs and Clinical Trials Rules (NDCTR), 2019, and conform to national and international Good Clinical Practice (GCP) guidelines.

In this article, we break down the process of EC registration, provide insights into regulatory expectations, and offer best practices for maintaining ongoing compliance in the context of Indian clinical trials.

Table of Contents

Background / Regulatory Framework

The evolution of EC oversight in India has been driven by the need to bring ethical governance in line with international standards. Major regulatory reforms were prompted by global scrutiny, increased clinical trial activity, and ethical lapses reported in media and inspections.

Historical Evolution

Prior to 2013, there

was no formal requirement for ECs to register with CDSCO. However, following a Supreme Court directive and public concern over trial conduct, India introduced mandatory EC registration in 2013. This was later codified under the NDCTR, 2019.

NDCTR 2019: Legal Mandate for ECs

The NDCTR 2019 mandates that all ECs involved in reviewing clinical trial protocols be registered with the CDSCO. No clinical trial involving a new drug or investigational new drug (IND) can begin unless the trial has been approved by a registered EC. Additionally, ECs must be re-registered every five years and report any changes to their composition or SOPs.

Core Clinical Trial Insights

Who Needs to Register?

All Institutional Ethics Committees (IECs) and Independent Ethics Committees (IECs) involved in reviewing and approving clinical trial protocols, academic research, or bioavailability/bioequivalence studies must be registered. Institutions such as hospitals, medical colleges, and research centers are required to ensure their EC is compliant.

Types of Ethics Committees

Institutional Ethics Committees (IECs): Attached to a particular institution or hospital. These usually oversee trials conducted at the same institution.
Independent Ethics Committees: Function independently and may review protocols for multiple trial sites.

Registration Process Overview

Form CT-02 Submission: This is the formal application form for EC registration.
Portal Access: ECs must submit documents via the CDSCO SUGAM portal.
Document Requirements: EC composition, SOPs, member CVs, GCP certificates, infrastructure details, and past review logs.
Verification and Approval: CDSCO reviews the application and grants registration if found satisfactory. Registration numbers are issued and publicly listed.

Documentation Checklist

Constitution of the EC (minimum 7 members with varied backgrounds).
SOPs covering review process, quorum, expedited review, SAE handling, etc.
CVs and GCP training certificates of all members.
Details of facilities including meeting rooms, documentation systems, and archiving processes.
Previous meeting minutes, decisions, and attendance logs.

Registration Validity and Renewal

The EC registration is valid for a period of five years. A renewal application must be submitted at least 3 months before the expiry date. During renewal, updated member details and SOP revisions must be submitted for verification.

Responsibilities of a Registered Ethics Committee

Ensure that only scientifically and ethically sound research is approved.
Monitor ongoing trials through progress reports and site visits if required.
Maintain confidentiality and ensure impartiality in decisions.
Report Serious Adverse Events (SAEs) to CDSCO within prescribed timelines.
Participate in CDSCO audits and inspections if selected.

Consequences of Non-Compliance

Conducting trials without EC registration or using an expired registration is a serious regulatory violation. Such studies may be suspended, and the institution can face sanctions, including disqualification from future trials. CDSCO regularly audits ECs and publishes updates on their registration status.

Best Practices & Preventive Measures

Maintain clear and updated SOPs aligned with ICMR and CDSCO expectations.
Train all EC members in GCP and regulatory guidelines regularly.
Use a robust document control system to store meeting records, decisions, and communications.
Conduct self-audits annually to ensure preparedness for CDSCO inspections.
Ensure quorum and diversity (legal expert, lay person, etc.) in all decisions.

Scientific & Regulatory Evidence

NDCTR 2019: Official rulebook governing EC roles and responsibilities in India.
ICMR National Ethical Guidelines (2017): Benchmark for ethical oversight in biomedical research.
GCP Guidelines – ICH E6(R2): International standard referenced by Indian regulators.
CDSCO Notifications & FAQs: Clarify common doubts around EC operations and obligations.

Special Considerations

Multicentric Trials: Each trial site must have a local EC, or the trial must be reviewed by a central EC registered with CDSCO.

Foreign Sponsors: Must verify that the local EC approving their trial is currently registered. They may include EC registration proof in their clinical trial application dossier.

Digital Platforms: ECs are encouraged to adopt digital tools for documentation, meeting scheduling, and compliance audits. However, data security and confidentiality must be ensured.

When Sponsors Should Seek Regulatory Advice

When submitting trials to ECs not currently registered or undergoing renewal.
If the EC composition changes significantly.
For international trials where mutual recognition of ethics reviews is being sought.
When setting up a new EC and aligning it with NDCTR expectations.
If faced with conflicting ethical decisions across sites or studies.

Sponsors and CROs may consult CDSCO or the ICMR Bioethics Unit for guidance on complex ethical situations or registration issues.

FAQs

1. Is EC registration mandatory for all clinical trials in India?

Yes. Under NDCTR 2019, no clinical trial can be initiated in India unless it has been reviewed and approved by an EC registered with CDSCO.

2. How long does EC registration take?

It typically takes 4–8 weeks from submission through the SUGAM portal, provided all documents are in order.

3. What is the difference between Institutional and Independent ECs?

Institutional ECs are affiliated with a hospital or university, while Independent ECs operate standalone and may approve multiple site studies.

4. What happens if an EC’s registration expires?

The EC must stop reviewing new protocols. Ongoing trials must be transferred to a registered EC or paused until re-registration is completed.

5. Can a sponsor select any EC for their trial?

No. Sponsors must ensure the EC is registered with CDSCO and appropriately constituted. Preference is given to site-level ECs with relevant therapeutic expertise.

Conclusion & Call-to-Action

Ethics Committees are the ethical gatekeepers of clinical research in India. Ensuring their proper registration, training, and documentation is not just a regulatory requirement—it’s a fundamental safeguard for participants’ rights and well-being. Sponsors, investigators, and institutions must work proactively to align with CDSCO expectations and uphold global best practices. For customized support in EC setup, registration, or audits, consult with clinical regulatory experts or refer to ICMR and CDSCO guidance documents.